Skip to main content
. 2022 Jan 28;12:748403. doi: 10.3389/fonc.2022.748403

Figure 3.

Figure 3

PFKFB3 shifts CSC metabolism in ovarian cancer. (A) Relative mRNA expression of PFKFB3 in tumorsphere/monolayer and ALDH+CD44+/ALDH-CD44- cells via qPCR. (B) Protein expression of PFKFB3 in tumorsphere/monolayer and ALDH+CD44+/ALDH-CD44- cells, determined via immunoblotting; Relative PFKFB3 (C) mRNA and (D) protein expression in tumorspheres and ALDH+CD44+ cells transfected with control siRNA or siPFKFB3 duplexes and PFKFB3-overexpressing ALDH-CD44- cells, determined by qPCR and immunoblotting, respectively. (E) Relative lactate production and (F) oxygen consumption rate of PFKFB3-suppressing ALDH+CD44+ cells and PFKFB3-overexpressing ALDH-CD44- cells after 24 h incubation. (n = 3; *p < 0.05, **p < 0.01).